Related by context. Frequent words. (Click for all words.) 71 Pivotal Trial 71 prospective multicenter 71 multicentre 71 Phase III Clinical Trial 70 multicenter randomized 70 prospective observational 70 Clinical Trial Results 69 Acute Myocardial Infarction 68 Randomized 68 PRECISE 68 Phase III Trial 68 Pivotal Phase III 67 Thrombolysis 67 prospective randomized controlled 67 multicenter 67 Phase III randomized 66 Myocardial Infarction 66 placebo controlled clinical 66 Carotid 66 phase IIa 65 Pulmonary Arterial Hypertension 65 prospective randomized 65 Randomized Controlled Trial 65 Pivotal Phase 65 PREVAIL 65 label multicenter 65 Meta Analysis 64 multicenter randomized double 64 placebo controlled randomized 64 Pharmacokinetic 64 Monotherapy 64 Patients Treated 64 Phase Ib clinical 64 RADIANT 63 Benign Prostatic Hyperplasia 63 placebo controlled Phase 63 Overactive Bladder 63 Drug Eluting Stents 63 Targeted Therapy 63 multicenter clinical 62 Percutaneous Coronary Intervention 62 randomized Phase III 62 Radiation Therapy Oncology 62 Heart Failure Patients 62 Completes Enrollment 62 Stenting 62 ENDEAVOR 62 Study Demonstrates 62 Preclinical Data 62 Gynecologic Oncology Group 62 PRECiSE 61 Patient Enrollment 61 substudy 61 multicenter study 61 randomized controlled clinical 61 HALTS 61 EORTC 61 Postmenopausal Women 61 Clinical Study 61 Phase 1b clinical 61 Metastatic Melanoma 61 #:#-# [031] 60 Solid Tumors 60 TRITON TIMI 60 Systematic Review 60 Chronic Lymphocytic Leukemia 60 Ischemic 60 Clinical Trial 60 #:#-# [029] 60 Elderly Patients 60 Chronic Hepatitis C 60 Atopic Dermatitis 60 Vertebroplasty 60 J Am Coll 60 Natalizumab 60 ACCLAIM 60 Presents Positive 60 Coagulation 60 Drug Candidate 60 ATTRACT 60 randomized placebo controlled 59 double blinded placebo 59 Enoxaparin 59 placebo controlled 59 Arch Neurol 59 randomized clinical 59 blind randomized 59 blind randomized placebo 59 J Clin Oncol 59 Amrubicin 59 PFO closure 59 Rosuvastatin 59 Systemic Lupus Erythematosus 59 label dose escalation 59 blinded placebo controlled 59 nab paclitaxel 59 Drug Eluting Stent 59 interferon beta 1b 59 blind randomized controlled 59 Tolerability 59 Clinical Outcomes